CH625254A5 - - Google Patents

Download PDF

Info

Publication number
CH625254A5
CH625254A5 CH946879A CH946879A CH625254A5 CH 625254 A5 CH625254 A5 CH 625254A5 CH 946879 A CH946879 A CH 946879A CH 946879 A CH946879 A CH 946879A CH 625254 A5 CH625254 A5 CH 625254A5
Authority
CH
Switzerland
Prior art keywords
methyl
chloro
fluoro
diesters
preparation
Prior art date
Application number
CH946879A
Other languages
German (de)
English (en)
Inventor
Joao Emerico Villax
Original Assignee
Plurichemie Anstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plurichemie Anstalt filed Critical Plurichemie Anstalt
Publication of CH625254A5 publication Critical patent/CH625254A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH946879A 1974-03-27 1979-10-22 CH625254A5 (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT6163774 1974-03-27
PT6163674 1974-03-27
PT6163675 1975-03-10

Publications (1)

Publication Number Publication Date
CH625254A5 true CH625254A5 (xx) 1981-09-15

Family

ID=27354092

Family Applications (2)

Application Number Title Priority Date Filing Date
CH392475A CH622811A5 (xx) 1974-03-27 1975-03-26
CH946879A CH625254A5 (xx) 1974-03-27 1979-10-22

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH392475A CH622811A5 (xx) 1974-03-27 1975-03-26

Country Status (8)

Country Link
BE (1) BE827275A (xx)
CH (2) CH622811A5 (xx)
DK (1) DK153556C (xx)
FR (1) FR2274309A1 (xx)
GB (2) GB1510617A (xx)
IE (2) IE41138B1 (xx)
NZ (1) NZ177056A (xx)
SE (1) SE440656B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
IT1285770B1 (it) 1996-10-04 1998-06-18 Nicox Sa Composti corticoidei
CN102516348B (zh) * 2011-11-10 2013-11-13 中国科学院上海有机化学研究所 一种16s-甲基-20s-羟基孕甾化合物、合成方法及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070751A (en) * 1964-01-28 1967-06-01 Glaxo Lab Ltd 17-esters of 17-hydroxy-21-desoxy-steroids
GB1139505A (en) * 1965-06-23 1969-01-08 Glaxo Lab Ltd A process for the production of 17-‡-monoesters of 17-‡-hydroxy-20-keto-steroids
US3383394A (en) * 1965-08-30 1968-05-14 Schering Corp Novel 17-acylating process and products thereof
CH481085A (de) * 1965-08-30 1969-11-15 Scherico Ltd Verfahren zur Herstellung von 11B-Hydroxy-17 -alkanoyloxysteroiden der Pregnanreihe
BE788355A (fr) * 1971-09-07 1973-03-05 Merck Patent Gmbh Esters de 9 alpha-fluoro-16-methylene-prednisolone

Also Published As

Publication number Publication date
FR2274309B1 (xx) 1978-11-24
IE41137L (en) 1975-09-27
DK153556C (da) 1988-12-05
DK129575A (xx) 1975-09-28
FR2274309A1 (fr) 1976-01-09
GB1511820A (en) 1978-05-24
SE440656B (sv) 1985-08-12
NZ177056A (en) 1978-09-20
IE41137B1 (en) 1979-10-24
GB1510617A (en) 1978-05-10
BE827275A (fr) 1975-07-16
IE41138B1 (en) 1979-10-24
CH622811A5 (xx) 1981-04-30
DK153556B (da) 1988-07-25
SE7803041L (sv) 1978-03-16

Similar Documents

Publication Publication Date Title
DE2707336C2 (xx)
EP0135476B1 (de) Steroid Carbonsäureester
DE2512915C2 (xx)
CH629825A5 (de) Verfahren zur herstellung von terpenoiden estern von steroiden der pregnanreihe.
CH505802A (de) Verfahren zur Herstellung von Estern von 17a-Hydroxysteroiden der Pregnanreihe
CH644614A5 (de) 17-alpha-acyloxy-5-beta- und 17-alpha-acyloxy-5-alpha-corticoide.
CH504423A (de) Verfahren zur Herstellung von 17a-Mono-kohlenwasserstoffcarbonsäureestern von 9a, 11B-Dihalogen-16a-niedrigalkyl-1,4-pregnadien-17a, 21-diol-3,20-dionen und ihren 4-Pregnen-Analoga
CH625254A5 (xx)
DE2852055C2 (xx)
CH641476A5 (de) Hydrocortison-17,21-diester und verfahren zu deren herstellung.
CH655320A5 (de) Verfahren zur herstellung von corticosteroid-estern mittels selektiver solvolyse.
EP0077541B1 (de) Delta-1,3,5-3-Chlor-11-Beta,16-Alpha,17-Alpha,21-tetra-(hydroxy)-pregnan-20-on-16,17-acetonidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2365992A1 (de) 6 alpha-fluor-17,21-dihydroxy-16 beta-methylpregna-4,9(11)-dien-3,20- dion-17,21-diacetat und verfahren zu dessen herstellung
CH493510A (de) Verfahren zur Herstellung von neuen Steroidderivaten
AT391703B (de) Verfahren zur herstellung von 16alpha- und 16beta-methyl-9alpha-chlor- oder -fluor-17-mono- und 17,21-diestern der prednisolonserie
DE2448662C2 (de) 6α-Fluor-16α-methyl-1,4,8-pregnatrien-3,20-dion-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CH626633A5 (xx)
AT357696B (de) Verfahren zur herstellung von 16alpha- und 16beta-methyl-9alpha-chlor- oder -fluor-21- -desoxyprednisolonestern und -aethern
EP0049783B1 (de) D-Homo-kortikoide, ihre Herstellung und Verwendung
DE2055221A1 (en) 17-acyloxy-3-keto-pregn-4-enes prepn - by acylating 17-hydroxy steroids in presence ofstannic chloride
DE1793461A1 (de) 21-(Cyclobutyl-carbonsaeure)-ester von Steroidderivaten und Verfahren zu ihrer Herstellung
DE1768673C (de) 6 alpha, 9 alpha-Difluorprednisolon-17,21-diester
DE1296631B (de) Verfahren zur Herstellung von 16-Fluormethylen-steroiden
AT362888B (de) Verfahren zur herstellung von neuen estern von androstadien-17-carbonsaeuren
DE1593518C3 (de) Verfahren zur Herstellung eines 17 alpha-Esters der Pregnanreihe

Legal Events

Date Code Title Description
PL Patent ceased